Scribd Logo
Upload

Welcome to Scribd!

  • Mind Mapping Fix

    Uploaded by

    lelighghgh
    108 views3 pages
    This document discusses the classification, pathogenesis, and treatment of dyslipidemia. It classifies dyslipidemia into primary and secondary types, endogenous and exogenous forms, and discusses common etiologies like obesity, diabetes, metabolic syndrome, and kidney disease. Treatment approaches include lifestyle modifications like diet and exercise as well as pharmacologic therapies. The main pharmacologic approaches mentioned are statins, fibrates, niacin, and resin drugs, with statins being the first line treatment for many dyslipidemias.

    Original Description:

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document discusses the classification, pathogenesis, and treatment of dyslipidemia. It classifies dyslipidemia into primary and secondary types, endogenous and exogenous forms, and discusses common etiologies like obesity, diabetes, metabolic syndrome, and kidney disease. Treatment approaches include lifestyle modifications like diet and exercise as well as pharmacologic therapies. The main pharmacologic approaches mentioned are statins, fibrates, niacin, and resin drugs, with statins being the first line treatment for many dyslipidemias.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    108 views3 pages

    Mind Mapping Fix

    Uploaded by

    lelighghgh
    This document discusses the classification, pathogenesis, and treatment of dyslipidemia. It classifies dyslipidemia into primary and secondary types, endogenous and exogenous forms, and discusses common etiologies like obesity, diabetes, metabolic syndrome, and kidney disease. Treatment approaches include lifestyle modifications like diet and exercise as well as pharmacologic therapies. The main pharmacologic approaches mentioned are statins, fibrates, niacin, and resin drugs, with statins being the first line treatment for many dyslipidemias.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    of 3

    NONFARMAKOLOGI

    Diet rendah lemak

    Gol. Statin

    Diet tinggi serat

    Mengikat asam empedu dalam sal.cerna

    Menghambat sintesis kolesterol di hati dg menghambat enzim

    Gol. Fibrat

    Olahraga

    Gol. Resin
    Menghambat hidrolisis TG oleh hormon sensitifitas

    Menjaga BB ideal
    Berhenti merokok

    Produksi apoC-III

    FARMAKOLOGI

    Gol. Niasin

    TERAPI

    Hiperkolesterolemia
    EAS

    Penanganan Khusus

    Dislipidemia Campuran

    DISLIPIDEMIA
    Hipertrigliseridemia

    Fenotipik

    Penyakit Jantung Koroner

    Dislipidemia
    Gol. statin

    WHO

    TIPE

    Dislipidemia Kombinasi
    Hiperkolesterolemia

    Penyakit Diabetes Mellitus Tipe 2

    Dislipidemia Campuran

    Patogenik
    Statin dengan gol. Lain seperti bile acid resin, fibrat dan niacin

    Dislipidemia Endogen
    Primer

    Sekunder

    Dislipidemia Remnan

    Hiperkolesterolemia Poligenik

    Penyakit Gagal Ginjal

    Hiperkolesterolemia Familial
    Gol. Statin

    Dislipidemia Remnan

    Penyakit
    Hipertensi
    statin potensi menengah dgndDosis yang
    relatif rendah

    Hiperlipidemia Kombinasi Familial

    Penyakit
    Obesitas

    Peningkatan Kolesterol HDL

    Penyakit Sindrom
    Metabolik
    Gol.
    statin
    Penyakit
    Aterosklerosis

    Gol.
    statin

    Hipertrigliseridemia Familial

    Peningkatan Apolipoprotein B

    Gol.
    Statin

    Gol.
    statin
    Penyakit
    Hati

    Sindrom Kilomikron

    TUGAS
    MAIN MAPING

    Disusun Oleh :

    Febrianti Rizka
    14811029
    Safrina Kusuma Dewi
    14811042
    Ria Rahayu
    14811048
    Yeni Ridayani
    14811071
    Ade Ria Ayu Fardhiani
    14811073
    Rachmawati Martha Sari 14811083
    Rina Karina Arifianty 14811087
    Arvina Damayanti
    14811096
    Angriani Sahada
    14811097
    Arif Munandar
    14811100

    PROGRAM STUDI PROFESI APOTEKER


    FAKULTAS MATEMATIKA DAN ILMU PENGETAHUAN ALAM
    UNIVERSITAS ISLAM INDONESIA
    2014
    Daftar Pustaka

    1. George F., Jiri J. F., Jacques J.G, Ruth McPherson, 2000, Recommendations for the
    management and treatment of dyslipidemia, CMAJ, 162(10):1441-7.
    2. John, Bosomworth, 2013, Approach to identifying and managing atherogenic
    dyslipidemia A metabolic consequence of obesity and diabetes, Can Fam
    Physician, 59: 1169-1180.
    3. Rohman, S., 2007, Patogenesis dan Terapi Sindroma Metabolik, J Kardiol Ind,
    28:160-168.
    4. Silva PM1, Cardoso, S.M., Ferreira, A.M., 2014, Persistent lipid abnormalities in
    patients with hypertension and dyslipidemia treated with statins: results of the
    Portuguese hypertensive subpopulation of the Dyslipidemia International Study
    (DYSIS), Clin Exp Hypertens.
    5. Walker, Roger. 2007. Clinical Pharmacy and Therapeutics. Elsevier Limited.
    British.

    You might also like